Learn From the Experts About Collaborative Practice in the Management of Cancer Patients
Develop your expertise in side effect management, recognition, and timing for immunotherapy-related adverse events for several disease states, including melanoma, non–small cell lung cancer, and urothelial carcinoma. Join the presenters as they show how to put the information into practice through case-based interactive discussions.
Upon completion of this activity, participants will be able to:
- Differentiate between early and latent adverse effects associated with immunotherapeutic agents.
- Recognize the differences between the immunotherapeutic agents and of chemotherapeutic agents: mechanisms of action, adverse effects, and toxicity management.
- Describe the concept of “pseudo-progression” associated with immunotherapeutic agents and identify ways to differentiate this occurrence from real disease progression.